Why the Medical Developments International Ltd share price is climbing today

Medical Developments International Ltd (ASX:MVP) shareholders hope to profit from the green whistle.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in healthcare business Medical Developments International Ltd (ASX: MVP) climbed 2.7% to $6.12 in morning trade after the firm announced it has received marketing authorisation in France for its Penthrox pain management product.

Penthrox is more commonly known as the 'green whistle' in its use as an inhalation medical device by emergency response teams to provide pain relief to accident and emergency or trauma victims.

It is currently sold in 15 countries worldwide including Australia, the UK, South Africa and Singapore with company estimates that the global market could be worth more than $2 billion.

The approval in France means the company can reportedly begin to sell the product in France and Belgium, with a milestone payment of US$3 million also triggered from its French pharmaceutical partner Mundipharma.

The company also stated that French approval is significant as it may open the door to a "Decentralised Approval process" across the 28 other countries in the European Union.

The stock has gained 157% over the course of the past year as its international expansion plans progress impressively, with potential approval in the giant US healthcare market another milestone on investors' minds.

However, the US tends to be more of a cash cow for drugs like Botox, Viagra or anti-depressants where people are prepared to privately fork out large sums for popular but non-essential drugs. Success in the US is not crucial to Medical Developments International though, as Penthrox is an emergency services drug with genuine global potential both inside and outside the US.

Other ASX-listed junior medical device businesses commonly target the lucrative US private healthcare market before trying to grow internationally. Examples include sleep treatment specialist Somonmed Limited (ASX: SOM) and hospital disinfectant specialist Nanonsonics Ltd (ASX: NAN).

Overall, Medical Developments has an exciting outlook, although it's no secret with the company now valued at around $345 million despite it delivering EBIT of just $318,000 on revenues of $5.9 million for the six-month period ending December 31 2015.

The company will need to deliver on its growth prospects in Europe and elsewhere to justify this valuation and investors should be sure not to pay too much if they are keen to grab a slice of this globally growing healthcare business.

Motley Fool contributor Tom Richardson has no position in any stocks mentioned. You can find Tom on Twitter @tommyr345 The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »